Somatostatinski receptor 5

edit
Somatostatinski receptor 5
Identifikatori
SimboliSSTR5;
Vanjski IDOMIM: 182455 MGI: 894282 HomoloGene: 20287 IUPHAR: sst5 GeneCards: SSTR5 Gene
Ontologija gena
Molekularna funkcija • aktivnost rodopsinu-sličnog receptora
• receptorska aktivnost
• aktivnost somatostatinskog receptora
Celularna komponenta • integralno sa ćelijskom membranom
• membrana
Biološki proces • prenos signala
• G-proteinska signalizacija, spregnuta sa ciklično nukleotidnim sekundarnim glasnikom
• negativna regulacija ćelijske proliferacije
• glukozna homeostaza
• regulacija sekrecije insulina
Pregled RNK izražavanja
podaci
Ortolozi
VrstaČovekMiš
Entrez675520609
EnsemblENSG00000162009ENSMUSG00000050824
UniProtP35346O35715
RefSeq (mRNA)NM_001053NM_011425
RefSeq (protein)NP_001044NP_035555
Lokacija (UCSC)Chr 16:
1.07 - 1.07 Mb		Chr 17:
25.22 - 25.22 Mb
PubMed pretraga[1][2]

Somatostatinski receptor tip 5 je protein koji je kod čoveka kodiran SSTR5 genom.[1]

Somatostatin deluje na mnogim lokacijama i inhibira oslobađanje hormona i drugih sekretornih proteina. Biološki efekti somatostatina su posredovani familijom G protein-spregnutih receptora čije izražavanje je specifično za pojedina tkiva.[2]

Vidi još

  • Somatostatinski receptor

Reference

  1. ↑ Takeda J, Fernald AA, Yamagata K, Le Beau MM, Bell GI (Aug 1995). „Localization of human somatostatin receptor 5 gene (SSTR5) to chromosome band 16p13.3 by fluorescence in situ hybridization”. Genomics 26 (3): 638–9. DOI:10.1016/0888-7543(95)80195-R. PMID 7607700. 
  2. ↑ „Entrez Gene: SSTR5 somatostatin receptor 5”. 

Literatura

  • Yamada Y, Post SR, Wang K, et al. (1992). „Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.”. Proc. Natl. Acad. Sci. U.S.A. 89 (1): 251–5. DOI:10.1073/pnas.89.1.251. PMC 48214. PMID 1346068. 
  • Montminy MR, Goodman RH, Horovitch SJ, Habener JF (1984). „Primary structure of the gene encoding rat preprosomatostatin.”. Proc. Natl. Acad. Sci. U.S.A. 81 (11): 3337–40. DOI:10.1073/pnas.81.11.3337. PMC 345502. PMID 6145156. 
  • Panetta R, Greenwood MT, Warszynska A, et al. (1994). „Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.”. Mol. Pharmacol. 45 (3): 417–27. PMID 7908405. 
  • O'Carroll AM, Raynor K, Lolait SJ, Reisine T (1994). „Characterization of cloned human somatostatin receptor SSTR5.”. Mol. Pharmacol. 46 (2): 291–8. PMID 8078491. 
  • Yamada Y, Kagimoto S, Kubota A, et al. (1993). „Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype.”. Biochem. Biophys. Res. Commun. 195 (2): 844–52. DOI:10.1006/bbrc.1993.2122. PMID 8373420. 
  • Yamada Y, Stoffel M, Espinosa R, et al. (1993). „Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms.”. Genomics 15 (2): 449–52. DOI:10.1006/geno.1993.1088. PMID 8449518. 
  • Fukusumi S, Kitada C, Takekawa S, et al. (1997). „Identification and characterization of a novel human cortistatin-like peptide.”. Biochem. Biophys. Res. Commun. 232 (1): 157–63. DOI:10.1006/bbrc.1997.6252. PMID 9125122. 
  • Ain KB, Taylor KD, Tofiq S, Venkataraman G (1997). „Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.”. J. Clin. Endocrinol. Metab. 82 (6): 1857–62. DOI:10.1210/jc.82.6.1857. PMID 9177396. 
  • de Lecea L, Ruiz-Lozano P, Danielson PE, et al. (1997). „Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin.”. Genomics 42 (3): 499–506. DOI:10.1006/geno.1997.4763. PMID 9205124. 
  • Jaïs P, Terris B, Ruszniewski P, et al. (1997). „Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours.”. Eur. J. Clin. Invest. 27 (8): 639–44. DOI:10.1046/j.1365-2362.1997.1740719.x. PMID 9279525. 
  • Hukovic N, Panetta R, Kumar U, et al. (1998). „The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization.”. J. Biol. Chem. 273 (33): 21416–22. DOI:10.1074/jbc.273.33.21416. PMID 9694905. 
  • Sharma K, Patel YC, Srikant CB (1999). „C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest.”. Mol. Endocrinol. 13 (1): 82–90. DOI:10.1210/me.13.1.82. PMID 9892014. 
  • Kumar U, Sasi R, Suresh S, et al. (1999). „Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.”. Diabetes 48 (1): 77–85. DOI:10.2337/diabetes.48.1.77. PMID 9892225. 
  • Rocheville M, Lange DC, Kumar U, et al. (2000). „Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.”. J. Biol. Chem. 275 (11): 7862–9. DOI:10.1074/jbc.275.11.7862. PMID 10713101. 
  • Rocheville M, Lange DC, Kumar U, et al. (2000). „Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.”. Science 288 (5463): 154–7. DOI:10.1126/science.288.5463.154. PMID 10753124. 
  • Daniels RJ, Peden JF, Lloyd C, et al. (2001). „Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16.”. Hum. Mol. Genet. 10 (4): 339–52. DOI:10.1093/hmg/10.4.339. PMID 11157797. 
  • Ballarè E, Persani L, Lania AG, et al. (2001). „Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment.”. J. Clin. Endocrinol. Metab. 86 (8): 3809–14. DOI:10.1210/jc.86.8.3809. PMID 11502816. 
  • Pasquali D, Notaro A, Esposito D, et al. (2002). „[Somatostatin receptor genes expression and effects of octreotide on orbital fibroblasts from Graves' ophthalmopathy]”. Minerva Endocrinol. 26 (3): 175–9. PMID 11753241. 
  • Papotti M, Bongiovanni M, Volante M, et al. (2002). „Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.”. Virchows Arch. 440 (5): 461–75. DOI:10.1007/s00428-002-0609-x. PMID 12021920. 

Spoljašnje veze

  • „Somatostatin Receptors: sst5”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-03-03. 
  • MeSH somatostatin+receptor+5
  • p
  • r
  • u
Klasa A: Rodopsinu slični
α1 (A, B, D) • α2 (A, B, C) • β1 • β2 • β3
Adenozinski (A1, A2A, A2B, A3) • P2Y (1, 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14)
(svi osim 5-HT3) 5-HT1 (A, B, D, E, F) • 5-HT2 (A, B, C) • 5-HT (4, 5A, 6, 7)
Drugi
Acetilholin (M1, M2, M3, M4, M5) • Dopamin (D1, D2, D3, D4, D5) • Histamin (H1, H2, H3, H4) • Melatonin (1A, 1B, 1C) • TAAR (1, 2, 3, 5, 6, 8, 9)
Metaboliti i
signalni molekuli
CysLT (1, 2) • LTB4 (1, 2) • FPRL1 • OXE • Prostaglandin (DP (1, 2), EP (1, 2, 3, 4), FP) • Prostaciklin • Tromboksan
Drugi
Žučna kiselina • Kanabinoidni (CB1, CB2, GPR (18, 55, 119)) • EBI2 • Estrogen • Slobodna masna kiselina (1, 2, 3, 4) • Laktat  • Lizofosfatidna kiselina (1, 2, 3, 4, 5, 6)  • Lizofosfolipid (1, 2, 3, 4, 5, 6, 7, 8) • Niacin (1, 2) • Oksoglutarat • PAF • Sfingozin-1-fosfat (1, 2, 3, 4, 5) • Sukcinat
Peptid
B/W (1, 2) • FF (1, 2) • S • Y (1, 2, 4, 5) • Neuromedin (B, U (1, 2)) • Neurotenzin (1, 2)
Drugi
Anafilatoksin (C3a, C5a) • Angiotenzin (1, 2) • Apelin • Bombezin (BRS3, GRPR, NMBR) • Bradikinin (B1, B2) • Hemokin • Holecistokinin (A, B) • Endotelin (A, B) • Formil peptid (1, 2, 3) • FSH • Galanin (1, 2, 3) • GHB receptor • Gonadotropin-oslobađajući hormon (1, 2) • Grelin • Kispeptin • Luteinizirajući hormon/horiogonadotropin • MAS (1, 1L, D, E, F, G, X1, X2, X3, X4) • Melanokortin (1, 2, 3, 4, 5) • MCHR (1, 2) • Motilin • Opioidni (δ, κ, μ, Nociceptin & ζ, ali ne σ) • Oreksin (1, 2) • Oksitocin • Prokineticin (1, 2) • Prolaktin-oslobađajući peptid • Relaksin (1, 2, 3, 4) • Somatostatin (1, 2, 3, 4, 5) • Tahikinin (1, 2, 3) • Tirotropin • Tirotropin-oslobađajući hormon • Urotenzin-II • Vazopresin (1A, 1B, 2)
Razno
GPR (1, 3, 4, 6, 12, 15, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 31, 32, 33, 34, 35, 37, 39, 42, 44, 45, 50, 52, 55, 61, 62, 63, 65, 68, 75, 77, 78, 81, 82, 83, 84, 85, 87, 88, 92, 101, 103, 109A, 109B, 119, 120, 132, 135, 137B, 139, 141, 142, 146, 148, 149, 150, 151, 152, 153, 160, 161, 162, 171, 173, 174, 176, 177, 182, 183)
Drugi
Adrenomedulin • Mirisni • Opsin (3, 4, 5, 1LW, 1MW, 1SW, RGR, RRH) • Proteazom-aktivirani (1, 2, 3, 4) • SREB (1, 2, 3)
Klasa B: Sekretinu slični
GPR (56, 64, 97, 98, 110, 111, 112, 113, 114, 115, 116, 123, 124, 125, 126, 128, 133, 143, 144, 155, 157)
Drugi
Klasa C: Metabotropni
glutamat / feromon
TAS1R (1, 2, 3) • TAS2R (1, 3, 4, 5, 8, 9, 10, 12, 13, 14, 16, 19, 20, 30, 31, 38, 39, 40, 41, 42, 43, 45, 46, 50)
Drugi
Klasa F:
Frizzled / Zaglađeni
Uvojiti
Frizzled (1, 2, 3, 4, 5, 6, 7, 8, 9, 10)
Zaglađeni
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
  • p
  • r
  • u
Neuropeptidni receptori
Hormonski receptori
Drugi
Opioidni receptori
Drugi neuropeptidni receptori
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)